Valley National Bancorp operates as the holding company for Valley National Bank that provides various commercial, private banking, retail, insurance, and wealth management financial services products.
FAIL · Does not pass the screen
14.06 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 22:21 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price14.06 USD at the 23 Oct 2026 close
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.09)
Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 14.06 against the desk's fair-value range, base estimate 18.00, over the last year.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.09, read 2026-10-27
Ethical does not pass the values gate
Price14.06 USD
Fair value18.00
Ethical score30.0/100
Our investment reviews on this name
2026-10-29Read Markup14.06+0.0% to today ✓Markdown gives way to Markup
2026-09-16Read Markdown13.85+1.5% to today Accumulation gives way to Markdown after a 5% slide in 11 weeks
2026-07-02Read Accumulation14.63-3.9% to today First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Valley National Bancorp holds its Markup at $14.06. The statistical read favours the sellers, held for 225 days.
As held on the ledger · 2026-10-23
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 225 days
Price at the screen
$14.06
Valuation
10.65 trailing · 8.14 forward price to earnings
Values screen
FAIL· score 30.0
Beta
1.09
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: bank
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: bank
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Valley National Bancorp does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VLY's ethical verdict changes
Today VLY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 28.0% margin of safety to the base estimate.
Third-party analyst targets: 14 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Ethics block this regional bank despite cheap multiples
Everyday loans and deposits keep regional banks like this one in business, yet the ethical screen rules it out immediately because banks sit on the prohibited list. That single filter overrides any surface appeal from a 9.8 times forward earnings multiple or 24 percent revenue growth.
The reported 34 percent profit margin and 9 percent return on equity look modest next to the 17 percent gap between the 14.95 share price and our 17.50 fair value. Analyst targets cluster around 16, but the low multiple on a cyclical lender often signals peak earnings rather than a bargain, especially with an unknown moat.
Currency and rate swings can quickly erode those margins while governance and lending standards add further uncertainty in the sector. We therefore pass outright. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VLY trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Markup · changed$14.06+11.9%Entry 15
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16.
2026-10-22Markdown$12.57+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$12.57+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$12.57+1.3%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$12.41+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$12.41+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Markdown$12.41+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Markdown$12.41-1.7%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Markdown$12.62-0.8%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-02Markdown$12.72-8.2%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 17% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 62%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (14 analysts) rates it buy, with a mean price target of $16.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.